V. Karamfilova, “Fibroblast Growth Factor 21 as a Marker of Prediabetes in Patients with Non-alcoholic Fatty Liver Disease”, Turkish Journal of Gastroenterology, vol. 33, no. 3, pp. 233–239, Jan. 2022.